What colour is semaglutide with B12, and what does it tell you?

Where the colour actually comes from

Cyanocobalamin, the synthetic form of B12 most commonly used in compounded injections, is chemically vivid. Even at small concentrations it gives liquids a recognisable pink-to-deep-red hue. Hydroxocobalamin, another injectable B12 form, produces a similar reddish tint. Methylcobalamin, a third variant, ranges from pale yellow to amber depending on concentration.

Semaglutide itself contributes nothing to that colour. The NHS medicines information for semaglutide describes the approved injection as a clear, colourless solution, consistent across Wegovy pens, which are manufactured to strict pharmaceutical standards by Novo Nordisk. So when someone describes a "pink semaglutide" or a "red semaglutide pen", they are almost always describing a compounded mixture, not a licensed product.

It is worth knowing this because colour is sometimes offered as a reassurance, a sign that B12 is present and the preparation is "real". In practice, pigment is easy to add to any liquid. It tells you very little about what else is in the vial, how stable the mixture is, or whether the semaglutide component is genuine, correctly dosed, or sterile. The colour of semaglutide in its authorised form is a useful baseline for exactly this reason.

Compounded semaglutide with B12: what UK guidance actually says

In the UK, Wegovy is the only semaglutide product licensed for weight management, and it does not contain B12. A preparation that combines semaglutide with B12 is a compounded medicine, produced by mixing ingredients outside the standard manufacturing process. Compounded medicines are not assessed by the MHRA for safety and efficacy in the same way licensed products are, and they are not subject to the same quality-control checks that apply to a pre-filled Wegovy pen.

The MHRA has warned publicly about unlicensed and counterfeit weight-loss injections circulating online, some of which have been found to contain wrong or absent active ingredients. Colour is not a reliable indicator of authenticity or safety. If you have questions about B12 and semaglutide and whether there is any clinical rationale for combining them, that conversation belongs with a prescriber rather than a product listing.

The only legal route to semaglutide for weight loss in the UK is a prescription from a qualified clinician, dispensed through a GPhC-registered pharmacy, in an authorised licensed form. Anything else sits outside the regulatory framework that protects you.

What the licensed evidence base covers, and what it does not

The clinical evidence for semaglutide in weight management is built on the STEP trial programme, which tested the 2.4mg weekly injection (Wegovy) against placebo, and our semaglutide information page covers the mechanism, dosing schedule, and what UK patients can realistically expect from a supervised treatment course. The STEP 1 trial, published in the New England Journal of Medicine, reported an average body-weight reduction of around 15% over 68 weeks. That evidence base covers semaglutide alone, given at specific doses, in a defined patient population. There is no equivalent trial evidence for semaglutide combined with B12 at any dose or ratio, meaning any claimed benefit from the combination is not supported by the same standard of proof.

The potential benefits sometimes cited for adding B12 are generally around supporting energy levels or addressing deficiency during calorie restriction. That is a nutritional question, not a pharmacological one, and a clinician can assess it without changing the semaglutide formulation itself. Oral or intramuscular B12 supplementation, prescribed separately where indicated, keeps your weight-loss medicine in its tested, authorised form.

For a broader look at how semaglutide works and what UK patients should know before starting, the NHS semaglutide medicines page is the clearest starting point. It covers the authorised formulation, common side effects and the clinical assessment process, none of which applies to compounded alternatives.

Colour changes and what to watch for in your pen

If you are using a licensed Wegovy pen and the solution looks anything other than clear and colourless (cloudy, discoloured, or containing particles) the manufacturer's guidance is clear: do not use it. Report any concerns about your pen to the pharmacy that dispensed it and, if you suspect a product fault, via the MHRA's Yellow Card scheme.

A colour change in a pen you know should be clear is a practical signal worth taking seriously. It can indicate degradation from exposure to heat or light, contamination, or a problem with the product itself. The same applies to changes in urine colour reported by some patients, worth flagging to a clinician if you notice anything unusual, since dehydration from GI side effects is a more common cause than the medicine itself.

If you are considering semaglutide for weight management and want to understand what a legitimate, clinically reviewed treatment pathway looks like, you are welcome to speak to our prescribers through a free consultation. A real clinician reads every submission the same day.